Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

39
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
39
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

33
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
33
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

24
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
24
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

43
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
43
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

45
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
45

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-post changes in agility, balance, and functional movement during short-term functional strength and balance training in national-level Kho-Kho players.

Scientific reports·2026
Same author

Mechanisms, clinical manifestations and management of cardiovascular diseases in ANCA-associated vasculitis.

Rheumatology (Oxford, England)·2026
Same author

Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with rituximab.

Frontiers in medicine·2026
Same author

A retrospective observational study of placenta accreta spectrum perioperative anaesthesia management in a tertiary care centre: A 25-year experience.

Indian journal of anaesthesia·2026
Same author

Synergistic Induction of Caspase-8-Mediated Leukaemic Cell Death by Fisetin and Pinocembrin.

International journal of molecular sciences·2026
Same author

Replaced right hepatic artery arising directly from the celiac trunk in a difficult pancreaticoduodenectomy for intraductal papillary mucinous neoplasm after cholangitis and biliary stenting: a case report and literature review.

Journal of surgical case reports·2026

Related Experiment Video

Updated: Sep 22, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

353

An update on polymyalgia rheumatica.

Ingrid E Lundberg1, Ankita Sharma2, Carl Turesson2,3

  • 1Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.

Journal of Internal Medicine
|May 25, 2022
PubMed
Summary
This summary is machine-generated.

Polymyalgia rheumatica (PMR) is a common inflammatory condition in older adults, primarily causing pain and stiffness. While glucocorticoids are effective, long-term use presents challenges due to side effects and potential relapses.

Keywords:
diagnosisepidemiologygiant cell arteritispolymyalgia rheumaticatemporal arteritistreatment

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

388
Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.1K

Related Experiment Videos

Last Updated: Sep 22, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

353
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

388
Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.1K

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Polymyalgia rheumatica (PMR) is the most prevalent inflammatory rheumatic disease in individuals over 50, predominantly affecting women.
  • Key symptoms include shoulder and pelvic girdle pain and morning stiffness, with potential for acute onset or gradual development.
  • Systemic symptoms like fatigue, fever, and weight loss are observed, possibly linked to interleukin-6 (IL-6) signaling.

Purpose of the Study:

  • To provide a comprehensive overview of polymyalgia rheumatica (PMR), encompassing its epidemiology, clinical presentation, and underlying pathology.
  • To discuss current diagnostic approaches, including clinical evaluation, laboratory markers, and emerging imaging techniques.
  • To review the therapeutic landscape of PMR, focusing on glucocorticoid treatment, its challenges, and potential adjunctive therapies.

Main Methods:

  • Literature review of epidemiological, clinical, and pathological studies on PMR.
  • Analysis of diagnostic criteria and the role of inflammatory markers and advanced imaging.
  • Evaluation of treatment strategies, including glucocorticoid efficacy, management of relapses, and exploration of steroid-sparing agents.

Main Results:

  • PMR is characterized by synovial and periarticular inflammation and muscular vasculopathy.
  • Diagnosis relies on clinical presentation, inflammatory markers, with imaging modalities showing promise but facing limitations.
  • Glucocorticoid therapy is effective but associated with significant long-term side effects and frequent relapses.

Conclusions:

  • PMR management requires careful consideration of glucocorticoid-related comorbidities and the potential for disease relapses.
  • Further research is needed on disease-modifying antirheumatic drugs and biologics as steroid-sparing options.
  • PMR is associated with giant cell arteritis, necessitating vigilant monitoring and potentially more intensive treatment.